These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25577849)
21. European guideline for the management of pediculosis pubis. Salavastru CM; Chosidow O; Janier M; Tiplica GS J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1425-1428. PubMed ID: 28714128 [TBL] [Abstract][Full Text] [Related]
22. A clinical review and history of pubic lice. Patel PU; Tan A; Levell NJ Clin Exp Dermatol; 2021 Oct; 46(7):1181-1188. PubMed ID: 33811771 [TBL] [Abstract][Full Text] [Related]
23. Head lice treatments and school policies in the US in an era of emerging resistance: a cost-effectiveness analysis. Gur I; Schneeweiss R Pharmacoeconomics; 2009; 27(9):725-34. PubMed ID: 19757866 [TBL] [Abstract][Full Text] [Related]
24. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Yoon KS; Gao JR; Lee SH; Clark JM; Brown L; Taplin D Arch Dermatol; 2003 Aug; 139(8):994-1000. PubMed ID: 12925385 [TBL] [Abstract][Full Text] [Related]
25. Pseudoresistance to pediculicides in a case of pubic lice. Helm KF; Lane AT; McPhilmy J Pediatr Dermatol; 1988 Aug; 5(3):187-8. PubMed ID: 2462732 [TBL] [Abstract][Full Text] [Related]
26. Assessment of topical versus oral ivermectin as a treatment for head lice. Ahmad HM; Abdel-Azim ES; Abdel-Aziz RT Dermatol Ther; 2014; 27(5):307-10. PubMed ID: 25041547 [TBL] [Abstract][Full Text] [Related]
28. [Management of lice infestations, recommendations for 2012]. Maillard A; Trellu LT; Eicher N; Michaud M; Laffitte E Rev Med Suisse; 2012 Apr; 8(335):726-8, 730-3. PubMed ID: 22545493 [TBL] [Abstract][Full Text] [Related]
29. Widespread insecticide resistance in head lice to the over-the-counter pediculocides in England, and the emergence of carbaryl resistance. Downs AM; Stafford KA; Hunt LP; Ravenscroft JC; Coles GC Br J Dermatol; 2002 Jan; 146(1):88-93. PubMed ID: 11841371 [TBL] [Abstract][Full Text] [Related]
32. Malathion for head lice and scabies: treatment and safety considerations. Idriss S; Levitt J J Drugs Dermatol; 2009 Aug; 8(8):715-20. PubMed ID: 19663108 [TBL] [Abstract][Full Text] [Related]
33. What's bugging you? An update on the treatment of head lice infestation. Tebruegge M; Pantazidou A; Curtis N Arch Dis Child Educ Pract Ed; 2011 Feb; 96(1):2-8. PubMed ID: 20688849 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of pediculicides for head lice. Burkhart CG; Burkhart CN Expert Opin Drug Saf; 2006 Jan; 5(1):169-79. PubMed ID: 16370965 [TBL] [Abstract][Full Text] [Related]
35. Topical ivermectin 0.5% lotion for treatment of head lice. Deeks LS; Naunton M; Currie MJ; Bowden FJ Ann Pharmacother; 2013 Sep; 47(9):1161-7. PubMed ID: 24259731 [TBL] [Abstract][Full Text] [Related]
36. Overview: the state of head lice management and control. Hansen RC Am J Manag Care; 2004 Sep; 10(9 Suppl):S260-3. PubMed ID: 15515629 [TBL] [Abstract][Full Text] [Related]
37. Clinical response and safety of malathion shampoo for treatment of head lice in a primary school. Wananukul S; Chatproedprai S; Tempark T; Wananukul W J Med Assoc Thai; 2011 Apr; 94(4):465-9. PubMed ID: 21591532 [TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of head lice in children. Mumcuoglu KY Paediatr Drugs; 1999; 1(3):211-8. PubMed ID: 10937452 [TBL] [Abstract][Full Text] [Related]